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ABSTRACT
DEV J. NAIR
State Medicaid Agencies Approaches to Quality Improvement: Implications for Policy,
Practice and Health Outcomes
(Under the direction of Russ Toal, Faculty Member)
Medicaid provides coverage to approximately 60 million individuals and is the largest
single payer of healthcare for children. Given this scope of the program and the
concentration of low-income and minority recipients, improvements to the quality of care
delivered to Medicaid members represents a significant opportunity to reduce health care
disparities and improve the overall delivery and quality of healthcare within the U.S. The
current study sought to evaluate the various approaches that state Medicaid agencies are
taking to assess and improve the quality of care to their managed care enrollees and the
degree to which they have implemented recommendations of various policy experts.
A survey was distributed to the Medicaid Directors of all 50 states. A total of 23 states
with risk based managed care programs responded, representing 62% of the states that
have managed care programs. The results indicated that nearly all states are utilizing
standard performance measures as one method to assess quality, with virtually all relying
on HEDIS measures for this purpose. Additional strategies that are being used include
public reporting of quality data and the use of pay-for-performance incentives; few states
are currently focusing on health information technology. Recommendations are made for
steps that the Medicaid program could take at both the state and federal level to further
develop quality improvement programs.

Index Words: Medicaid, Managed Care, Quality Improvement, Performance
Measurement, Pay for Performance, HEDIS.
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I.

INTRODUCTION

Medicaid was enacted in 1965 as Title XIX of the Social Security Act to provide
medical assistance to low income families, and aged and disabled individuals receiving
welfare benefits. Medicaid was designed as a federal and state partnership, with the
federal government establishing broad guidelines related to eligibility requirements and
minimum covered services. In return states receive matching funds of 50 to 76 percent of
their Medicaid expenditures (Kaiser Family Foundation, 2008 and 2009).
In 1967 Medicaid was expanded from a program that merely provided assistance
for diagnosed medical conditions to one that focused on the promotion of the healthy
growth and development of children. The Early Periodic Screening, Diagnostic, and
Treatment (EPSDT) program established requirements for assuring that children covered
by Medicaid received comprehensive preventive health, screening, and follow-up
(Rosenbaum, Mauery, Shin, & Hidalgo, 2005).
With eligibility requirements initially linked to the receipt of welfare payments,
Medicaid enrollments began to decline as states restricted requirements for Aid to
Families with Dependent Children (AFDC) in the 1970s and 80s. These reductions in
Medicaid coverage, along with reports of rising infant mortality rates, led to
congressional action to broaden access and coverage provisions for children and pregnant
women, and to tie eligibility requirements to family income, as opposed to the receipt of
welfare benefits (Mann, Rowland, & Garfield, 2003).

1

2
In an effort to contain escalating health care costs, to attain greater accountability
for access to care, and to improve the quality of health care services, state Medicaid
agencies began to contract with managed care organizations to provide services to
recipients. Such contracts began in the 1980’s, with enrollment into managed care plans
further expanding in 1997 with the passage of the Balanced Budget Act (BBA) that
allowed the mandatory enrollment of certain population groups without obtaining a
waiver through the Centers for Medicare and Medicaid Services (CMS) ("Balanced
Budget Act of 1997,"; Kaiser Family Foundation, 2008; Mann et al., 2003).
Despite efforts to expand access to quality health care for low income individuals,
significant disparities in access to care and health care outcomes continue to persist
(Agency for Healthcare Research and Quality, 2008). These disparities exist across
racial, ethnic, and socio-economic dimensions (Agency for Healthcare Research and
Quality, 2008), as well as across states and geographic regions (Shea, Davis, & Schor,
2008), and between individuals that have commercial health care coverage as opposed to
Medicaid coverage (Landon et al., 2007).
Medicaid provides coverage to approximately 60 million individuals (Smith,
Ellis, Edwards, & Rudowitz, 2009), of whom about 44 million are low income children
and their parents (Kaiser Family Foundation, 2009). Medicaid is the largest single payer
of healthcare for children, covering nearly 25% (Kaiser Commission on Medicaid and the
Uninsured, 2006; Kaiser Family Foundation, 2009). Additionally, Medicaid is
responsible for nearly 20% of all health care expenditures, covering over one of every 3
births, and over 40% of long-term care expenses (Kaiser Family Foundation, 2009)
Given this scope of the program and the concentration of low-income and minority

3
recipients, improvements to the quality of care delivered to Medicaid members represents
a significant opportunity to reduce health care disparities and improve the overall
delivery and quality of healthcare within the United States.
The number of Medicaid enrollees covered by some type of managed care plan
has been steadily increasing, with over 65% covered by managed care as of June 2006
(Finance Systems and Budget Group, 2006). Contracting with managed health care
organizations (MCOs) provides opportunities to hold these organizations accountable for
achieving specific goals related to access and quality. This contractual accountability is
one of the key tools that can be used to drive improvements in quality, and an advantage
when compared with trying to improve quality through a traditional system in which the
state directly reimburses providers for their services (Highsmith & Somers, 2000).
However, the literature on the impact of managed care on improved quality for
Medicaid recipients has been mixed. Some studies have found improvements in quality
such as increased use of controller medication and attendance at routine physician office
visits by asthmatics (Bollinger, Smith, LoCasale, & Blaisdell, 2007); and reductions in
hospitalizations for ambulatory sensitive conditions such as asthma and diabetes (Landon
& Epstein, 1999). Conversely, other studies have found decreases in the quality of care
subsequent to the implementation of managed care including increases in the number of
mental health readmissions (Fontanella, Zuravin, & Burry, 2006); and decreases in the
initiation of early prenatal care along with corresponding increases in the rate of
premature births, low-birth weight infants, and neonatal mortality (Aizer, Currie, &
Moretti, 2007).

4
The ability of states to hold MCOs accountable for improvements in quality is
dependent in part on having performance based contracts and developing effective
mechanisms of oversight (Fossett et al., 2000). In surveying state Medicaid agencies
regarding their oversight of managed health care plans, Landon, Tobias, and Epstein
(1998) found that few states were collecting systematic performance data on satisfaction,
access, or quality measures, or reporting significant improvements in quality. Likewise,
they also found few states that were reporting comparative data to either their health
plans or their enrollees. They suggest that while there are many challenges that states
face in improving quality health care for Medicaid enrollees, there also are significant
resources that states can leverage. These include the ability to compel changes through
regulation, as well as the ability to require (through contracting) the collection of
performance data and cooperation between health plans.
Corrigan, Eden, and Smith (2002) reviewed a number of strategies that they
believed were crucial for government agencies to maintain better oversight over quality.
Among their recommendations were:
•

Purchasing strategies that encourage adoption of best practices through the
public release of comparative data and rewards for performance;

•

Establishing standardized measurement and reporting practices across
various government programs;

•

Making comparative quality data available in a variety of formats to meet
the needs of different users (researchers, recipients, accreditors,
purchasers, advocates, etc.);
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•

Establishing core sets of standard performance measures; and

•

Greater standardization across state Medicaid and SCHIP programs with
respect to quality measures and reporting.

While there has been much growth and maturation of Medicaid managed care
programs over the past five to ten years, there is little systematic data on the approaches
used to measure and improve the quality of care, or on the impact that these approaches
have had in actual improvements in clinical processes or outcomes. This study examines
and updates the prior research that has evaluated approaches that states have used for
monitoring and improving the quality of care delivered through managed care
organizations. Specifically it investigates the degree to which prior recommendations
have been implemented, and whether there is an association between implementation of
these practices and improvements in quality. Finally, this paper concludes with
recommendations for future steps that CMS and state Medicaid agencies can take to
continue to improve of the quality of health care delivered to their recipients.

II.

REVIEW OF LITERATURE

Health Care Quality
Over the years quality researchers have come up with a variety of definitions and
concepts for measuring health care quality. Donabedian (1967) was one of the first to
focus on the concept of quality specific to health care, describing it in terms of structure,
process, and outcome.
Structure refers to the setting in which health care occurs and includes things such
as the type and qualifications of the practitioner providing the care; the configuration of
the organization providing the care; specific medical policies governing the provision of
card; as well as various mechanisms to monitor and/or reward specific processes or
outcomes.
Process refers to the implementation of specific practices that are known (or
believed) to lead to specific health outcomes. A number of organizations publish
evidence based practices (EBP); practices that are supported by the weight of research
evidence to be effective in treating a specific condition. Thus quality assessment may
focus on the extent to which these processes are consistently implemented.
While structure and process focus on whether certain elements thought to lead to
good health care are present, they do not automatically result in good outcomes. Thus
measurement of actual results, such as the number of patients that survive a heart attack,
or the rate of infant mortality, is important as well.
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Brook, McGlynn, & Cleary (1996) have suggested that for structure and process
variables to be credible, one must show that changes in either the structure or the process
result in differences in outcome. For example, research showing that the use of beta
blockers after a heart attack results in lower mortality lends credibility to a measure of
whether or not beta blockers are administered as an indicator of quality. Thus one
method of assessing quality is evaluating certain process of care against an ideal criterion,
such as that specified in a practice guideline.
Another method for assessing quality described by Brook et al (1996) is to
compare actual clinical outcomes of a specific provider, organization, or health plan with
the outcomes that would be expected under excellent, average, or poor care. For
example, research may have found that in a population of type II diabetics receiving
excellent care, one can expect that 95% will have normal glycosylated hemoglobin, while
with average care only 75% will have normal levels. The actual outcomes can then be
compared with these criteria to determine the level of quality of care delivered by a
specific provider.
Brook et al (1996) suggest that in may circumstances measures of process criteria
may be more accurate than measures that look solely at outcome. They note that patients
can have good outcomes even when they do not receive the standard of care. In addition,
the outcomes for some conditions, such as diabetic retinopathy, may not become evident
for many years. They argue that the areas where outcome measures will be most
appropriate are those in which there is strong evidence that the processes that can be
controlled by the physician lead to different outcomes; where these processes may be
difficult to measure (such as complex surgical procedures); and where there is a short
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interval between the process and the outcome. They suggest that risk adjusted mortality
rates following coronary artery bypass surgery is one example of appropriate use of
outcome measures.
The Institute of Medicine (IOM) defined quality of care as “…the degree to which
health services for individuals and populations increase the likelihood of desired health
outcomes and are consistent with current professional knowledge” (Institute of Medicine,
1990). The IOM has further concluded that the quality of health care can be defined with
a level of accuracy equal to many measures of clinical medicine. However, while health
care can be superb, in many instances it falls short of this, resulting in loss of life,
reduced functioning, and inefficient use of resources. These problems stem from the
overuse, underuse, and misuse of medical care (Institute of Medicine, 1998). They argue
for an approach that combines elements of regulation, quality improvement, and
marketplace strategies to improve the quality of health care.
Medicaid Quality
Studies evaluating the quality of care and service received by Medicaid recipients
has suggested that the overall quality is low and that it lags behind the quality of care
received by individuals covered by commercial insurance (Landon et al., 2007;
Thompson, Ryan, Pinidiya, & Bost, 2003). In a recent study, Landon et al (2007)
evaluated performance on a number of Healthcare Effectiveness Data Information Set
(HEDIS) measures to determine if there were differences in quality between commercial
managed care plans, managed care plans that served both commercial and Medicaid
members, and managed care plans that served only Medicaid members. They found that
members covered under commercial insurance had much higher quality scores than
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members covered by Medicaid. The quality scores for Medicaid recipients did not differ
between those served by Medicaid only plans, as opposed to those that served both
Medicaid and commercial populations. Thus, the authors suggest that the characteristics
of the health plan itself are less important than characteristics of the population, the
specific provider networks that are providing care, the patterns of seeking care, and the
degree to which individuals follow treatment recommendations. They note that the
differences in quality between members in commercial versus Medicaid plans were both
statistically and clinically significant, and that raising the performance in Medicaid plans
to that of commercial plans could result in several thousand fewer deaths annually.
Variations Across States
Shea, Davis, and Schor (2008) found that there are significant variations in the
quality and access to health care for children across the country. According to their
analysis there are leading states that consistently perform better on multiple indicators of
child health; these states typically have lower rates of uninsured children. The authors
suggest that from this standpoint Medicaid and the State Children’s Health Insurance
Program (SCHIP) play a significant role in providing increased access to health care
services for low income children, noting that with the enactment of SCHIP, the number
of states with more than 16% of their children uninsured has decreased from 12 to five.
They conclude that having better access to care and higher rates of insurance are
associated with better quality, noting that states with the lowest rates of un-insured have
higher rates of preventive care and better performance on other child health indicators.
However, having health care by itself does not guarantee quality, and there are also
significant variations among states within their Medicaid population.
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Along with differences in the quality of care received by Medicaid members in
general, studies have also found that there is significant variation in quality between
Medicaid recipients in different states. Ramírez de Arellano and Wolfe (2007) evaluated
state Medicaid programs in terms of their eligibility requirements, the scope of services
covered, quality of care, and reimbursement for providers. They concluded that overall,
state Medicaid programs have significant opportunities for improvement, with the highest
scoring state rating 645.9 points on a scale of 1000. They found significant discrepancies
between state Medicaid programs, with the lowest scoring state achieving half the points
of the highest scoring state. The discrepancies related to quality were even more striking,
with a seventeen fold difference between the highest and lowest scoring states.
Ramírez de Arellano and Wolfe (2007) conclude that there are no standard quality
measures that are used across all states, thus comparisons between states is difficult.
Their study evaluated areas such as whether the state had mandatory requirements for
reporting quality information, such as medical errors; measures of nursing home care,
including the percentage of facilities with deficiencies related to quality of care; data on
children receiving recommended immunizations, and children with emotional problems
that received mental health care. Due to the lack of standard Medicaid measures of
quality, some of the data they evaluated (such as immunization rates) was state-wide,
regardless of insurance coverage and thus represent a proxy for the quality of care
delivered under Medicaid. The authors conclude that their findings argue for the need to
redefine “quality control” as it pertains to Medicaid programs, noting that The Centers for
Medicare and Medicaid Services (CMS) currently require the monitoring of only
eligibility determinations, which relate to fiscal rather than quality of care outcomes.
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While CMS does not have significant requirements related to quality monitoring
of services provided under traditional Medicaid programs, they do have a number of
requirements for programs that contract with risk based managed care organizations.
Some of these requirements will be discussed further in the sections that follow.
Managed Medicaid and Impact on Quality
The number of Medicaid recipients in managed care programs has continued to
increase, from approximately 14% in 1991 (Highsmith & Somers, 2000) to 65% in 2006
(Office of the Inspector General, 2008). In 2008 over 30% of states increased the use of
managed care, either through the inclusion of persons with disabilities, expanding into
new geographic service areas, or requiring enrollment in managed care plans where it had
previously been voluntary (Smith et al., 2008). As noted earlier, state Medicaid programs
began to shift toward contracting with managed care organizations as a means of both
controlling escalating health care costs and improving access to care and the quality of
care. The impact of managed care on improving overall quality has been mixed, with
some studies finding that the greater accountability has led to improvements in quality,
while others have found that shifts in the traditional patterns of care and disruptions in the
structure of traditional safety net providers may have led to disruptions in care that has
had a negative impact on quality.
Bollinger et al. (2007) evaluating the impact of shifting from a traditional fee-forservice model to a managed care model, reported that this shift was associated with an
improvement in the utilization of services by children with asthma. Specifically they
found that over a four year period there was an increase in routine office visits, decreases
in emergency room and hospital admissions for asthma care, and corresponding increases
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in the use of inhaled corticosteroids, reflecting better use of controller (as opposed to
rescue) medications. This study used as its baseline, the first year of managed care, and
tracked improvement over the four year period from 1997 to 2000. Thus while the study
documented improvements in care over time following implementation of a managed
care program, there were no direct comparisons to the utilization of services prior to the
implementation of managed care. The authors conclude that some of the factors that may
have led to these improvements included more effective asthma case management, better
access to and use of preventive care visits, improved specialty care access, and increased
use of peak flow meters. However, their study design did not allow conclusions as to
whether these factors were related to improvement, or what role the managed care
organization, or state Medicaid agency may have played.
Cotter et al (2000) examined the impact of different types of managed care
arrangements on the rates of immunizations in Medicaid covered children. Specifically
the looked at differences between recipients that were enrolled in a primary care case
management program (PCCM), a voluntary managed care program, and a mandatory
managed care program. Recipients in a PCCM program are covered through the
traditional fee-for-service Medicaid program, however, they are assigned to a primary
care physician who is responsible for providing a medical home and coordinating their
medical care services. The study found that immunization rates were highest for
individuals enrolled in the PCCM program and lowest in the mandatory managed care
program. However, while the study findings suggested that type of managed care
program impacted the rate of immunization, they could not rule out other subject factors
since the different programs served different geographic regions of the state, with the
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PCCM program being active in both rural and urban areas and the two managed care
programs serving two different urban areas. The authors concluded that regardless of the
type of plan, all immunization rates were below the Healthy People 2010 goals and that
continued quality improvement efforts are essential. They noted that improved outcomes
will require monitoring by the state Medicaid agency to assure performance by managed
care programs.
Another study on the impact of implementing managed care for the Maryland
Medicaid program found that the rate of re-hospitalization for mental illness increased in
the year following managed care, when compared with the previous year (Fontanella et
al., 2006). The researchers examined changes in the rate of mental health readmissions
for adolescents that were hospitalized during the year before implementation of a
managed care program, and those hospitalized in the year following implementation.
They found that while the overall rate of readmission was not significantly greater in the
year following implementation of managed care, the proportion of adolescents with
multiple readmissions increased, with the proportion of those having three or more
readmissions more than doubling. The authors suggest that this increase in multiple
readmissions may reflect shorter hospital lengths of stay, with patients being discharged
before they were stable, along with diminished community resources to provide ongoing
outpatient care. They note that a number of safety net providers experienced significant
financial and administrative challenges following the impact of managed care which may
have adversely affected their ability to provide care. However, like many studies
evaluating the impact of managed care in Medicaid, this study only evaluated the initial
year of managed care implementation. Thus it is not possible to assess the degree to
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which maturation of the program, along with continued and perhaps more rigorous
oversight by the state Medicaid agency may lead to improvements in quality.
Aizer, Currie, and Moretti (2007) found that the implementation of mandatory
managed care for California Medicaid recipients was associated with decreases in the
initiation of timely prenatal care, and increases in the rate of neonatal mortality, low birth
weight and premature birth. They hypothesized that the emphasis of managed care
companies on reducing costs and utilization, led to a decrease in access to physicians, as
well as shifts towards hospitals with lower costs but poorer outcomes. They note that
under the program design, most of the managed care plans were not responsible for
paying for the subsequent health care costs of infants that required intensive care, or other
costly medical services. Thus, they suggest that the program design (and the services an
MCO is responsible for) can have a significant impact on the resultant quality and
outcomes.
State Oversight of Managed Medicaid Plans
Authors have suggested a number of ways that Medicaid agencies can utilize
arrangements with managed care organizations to improve the quality of health care.
Among the tools available to agencies are contractual requirements to meet specific
quality or access goals; requirements for conducting performance improvement projects,
the use of performance measurement in conjunction with specific financial or nonfinancial incentives and/or the public reporting of such data. There has been much
attention recently to the use of “pay for performance” incentives, or value based
purchasing as techniques for improving health care quality, although to date there have
been mixed results as to its effectiveness.
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Verdier and Hurley (2004) note that performance measurement of managed health
plans is a fundamental requirement for state Medicaid agencies exerting oversight over
the provision of health care services. While the nature and use of this data may vary with
the maturity of the program and the context within which it operates, they identify several
recommendations for Medicaid agencies to use in oversight of health plans.
Public Reporting
The authors suggest that ongoing evaluation and reporting is essential both to
drive improvements in quality and to demonstrate accountability and credibility with
external stakeholders. Among their conclusions, Verdier and Hurley (2004) suggest that
public reporting of data can be an important tool, provided that the data is credible and
that it is tailored to meet the different needs and understanding of different audiences.
For example, they suggest that health plan staff are more familiar with, and will make
better use of complex health data, than will legislators, recipients, or the media. They
report that the states that they surveyed used a variety of performance measures,
including encounter data, member complaints and grievances, provider participation,
HEDIS and Consumer Assessment of Healthcare Providers and Systems (CAHPS) data,
External Quality Review Organization (EQRO) reports, and MCO financial reports.
Their data suggested a greater comfort and acceptance with the public reporting of
standardized data such as HEDIS and CAHPS measures, as opposed to financial
measures. They also note that there is variation among states as to whether plan specific
data is reported publicly, but suggest that such specific reporting may be more effective
in improving performance when health plans feel that there is a need to compete with
each other to achieve higher enrollments.
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In a review of empirical literature, Fung, Lim, Mattke, Damberg, and Shekelle
(2008) found mixed evidence supporting a link between public reporting of data and
improvements in quality, or selection of a health plan. Their review identified two
randomized controlled trials both of which found no impact on the public reporting of
patient satisfaction data from the CAHPS and the selection of a health plan. However,
they cite other studies that found consumers reported being willing to accept health plans
with less generous coverage if those plans had higher satisfaction ratings, and that
consumers were more likely to switch from plans with lower reported quality. They
found no studies that linked reporting of health plan performance data and quality
improvement activity. They cited one study that found health plans voluntarily reporting
performance data (HEDIS and CAHPS measures) outperformed plans that did not report
this data. However, such findings could likely result from plans with better performance
being more likely to choose to report their data.
Similar to the conclusions of Verdier and Hurley (2004) Fung et al. (2008)
suggest that for public reporting to be successful in improving quality, it is important that
the reporting system be designed to achieve a specific purpose. Thus if the goal of a
reporting system is to assist consumers in choosing a health plan, then information must
be presented in ways that are comprehensible and relevant to their selection.
Contractual Requirements
One of the ways that states are theoretically able to achieve improvements in
quality through the use of managed care arrangements is by holding MCOs contractually
accountable for achieving certain performance goals. These may include requirements
related to accessibility of providers, as well as achieving specific levels of improvement
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in quality of care. Fossett et al. (2000) suggest that states must do three things in order to
be “prudent” purchasers of health care: 1) they must be able to specify their requirements
for performance in a measurable form; 2) they need to have a mechanism to identify
whether or not plans are complying with these requirements; and 3) there must be
consequences for the failure of plans to achieve these requirements.
In a survey of the practices at five states that had managed care contracts, the
authors found that most states were not effectively utilizing these tools to achieve
improvements in performance (Fossett et al., 2000). They found that states had few
specific performance requirements for quality, and where specific standards did exist,
there was often no penalty for failure to achieve the goal. The authors suggest that
becoming a prudent purchaser of health care is a complex task requiring significant
investment in data quality and systems for oversight. Additionally, while most states
have requirements for performance data, this has not consistently been analyzed or used
to improve quality.
Performance Measurement
The use of specific strategies to drive quality improvement has been evolving
over time, as state Medicaid managed care programs have become more mature. Studies
have found that while few states had any quality management activities in place in 1995,
by 2001, most were collecting some performance data related to satisfaction, access, or
quality (Landon, Schneider, Tobias, & Epstein, 2004). In a survey of state Medicaid
agencies, Landon et al. (2004) found that oversight of managed care plans has been
increasing, but that opportunities for further improvement exist. Similar to the findings
of Fossett et al. (2000), they found that while more states were collecting performance
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data, few states were specifying specific minimum standards for quality measures
(immunization rates were the exception). They also found that while there was an
increase in the reporting of comparative performance data, this was generally reported
directly to health plans, rather than to recipients or to the public. In addition, Landon et
al (2004) found that there had been little increase in the number of states that had
specifically targeted areas for improvement, although they did find that the number of
states reporting that improvement had occurred had increased from four in 1995, to 10 in
1998, and 17 in 2001. Finally, they found that while approximately one-third of states
had some sort of incentive or penalty system in place in 2001, in practice it was rarely
utilized. They conclude that while the monitoring of managed care plans by states was
steadily increasing from 1995 to 2001, to be effective in improving quality, data will need
to be tied to specific incentives and penalties (both financial and non-financial) for
achieving specific quality goals.
Performance Improvement Projects and Quality Collaboratives
One of the tools for improving the quality of care is through a performance
improvement project (PIP). CMS describes the purpose of a PIP as “…to assess and
improve processes, and thereby outcomes, of care.” (Centers for Medicare & Medicaid
Services, 2002a). According to CMS a PIP should focus on topics that are likely to
impact a significant portion of enrollees and are likely to have a substantial impact on
health, functional status, or satisfaction. PIPs should address a specific study question,
through the collection of valid data on a representative sample of the population in
question. Analysis of this data is used to generate hypotheses about current barriers to
improvement and potential interventions. These interventions are implemented with
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subsequent measurement to determine whether improvement has occurred and if so,
ongoing actions must assure the sustainability of these changes.
Performance improvement projects represent a methodical approach to evaluating
the current status of a health care process or outcome and implementing interventions
focused on improving this process or outcome. Under the BBA, PIPs are required by
managed care organizations serving Medicaid enrollees, and they must be validated by an
external quality review organization (EQRO). Thus the use of PIPs represent another
strategy that state Medicaid agencies can utilize to effect improvement in quality of care
and service.
Performance Improvement Projects can be done individually by each managed
care organization in a state, conducted collaboratively with other MCOs and stakeholders
within the state, or across different states.

Gold, Krissik, and Mittler (2006) describe a

series of quality collaborative work groups that were sponsored by Center for Health
Care Strategies (CHCS) and focused specifically on improvements in Medicaid managed
care enrollees. Gold et al. (2006) note that these collaboratives provide an opportunity
for health plans to share ideas with other Medicaid plans and to increase the rigor and
overall approach to quality improvement activities. The shared and collaborative focus
allows plans to learn from each other, while also providing external accountability for
maintaining focus that might otherwise be absent when the activity remains internal to
the plan itself.
While specific outcome data was not reported, the authors indicated that over
74% of the plans participating in an ongoing collaborative workgroup reported making
sustained changes to their programs, compared with only 53% of those that participated
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in single session groups. The authors suggest that a critical area for improvement lies in
the ability of plans to measure performance and in the development of standard measures
and goals to allow better tracking of progress. One of the benefits of the collaboration
was that several managed care plans used the workgroups as impetus to work with their
states Medicaid agencies on barriers to improvement that were external to the health plan
itself.
While there have been few detailed studies in this area, other authors have
suggested that addressing and improving health care across a state is too large a task for a
single state agency or individual MCO to have significant impact. They argue for the
importance of collaboratives that involve multiple stakeholders from the state Medicaid
agency, MCOs, providers, and others (Krissik, Ireys, Markus, & Rosenbaum, 2008).
Value Based Purchasing
In recent years there has been increasing interest and activity directed at aligning
provider compensation with the quality of care provided. In 2001, the Institute of
Medicine, in its report Crossing the Quality Chasm focused attention on serious problems
with the quality of medical care, and the need to align payment policies with quality
improvement (Institute of Medicine, 2001). CMS has also endorsed value based
purchasing, noting that current systems are based on rewarding the quantity, rather than
the quality of care. To achieve a vision of providing “the right care for every person,
every time”, CMS is shifting to a payment strategy for Medicare services that links the
amount of payment to the quality of care provided (CMS Hospital Pay for Performance
Work Group, 2007). Similarly, more state Medicaid agencies are employing pay for
performance strategies, as incentives for MCOs, or for health care providers.
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In an evaluation of pay for performance programs in five Medicaid health plans,
Felt-Lisk, Gimm, and Peterson (2007) found that while pay for performance was
effective in improving the timeliness of well baby care, that the effectiveness varied by
health plan. Based on their analysis of these programs they concluded that the more
successful health plans had more effective financial incentives, both in terms of amount
of the incentive, as well as providing incremental incentives for modest improvements.
They suggested that good communication between health plans and providers was
important, along with the provision of technical support to providers (such as providing
lists of children due for well-baby visits).
While the importance of Medicaid agencies basing MCO payments on
improvements in quality has been emphasized (Fossett et al., 2000), there have not been
any systematic evaluations as to the effectiveness of pay-for-performance at this level.
External Quality Review Organizations (EQRO)
Based on requirements outlined in the Balanced Budget Act (BBA), ("Balanced
Budget Act of 1997,")CMS began requiring states that contract with managed care
organizations develop a written strategy to monitor and assess the quality of care
provided to Medicaid recipients. CMS requires that the states specify the specific goals
and objectives that will be measured and the overall strategy for how these objectives will
be achieved. The state also must require that each MCO have an ongoing quality
assessment and performance improvement program that conducts performance
improvement projects; measures performance data; has mechanisms to detect over and
under utilization of services; and has mechanisms to assess the quality and
appropriateness of the care furnished to those with special health care needs (Centers for
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Medicare & Medicaid Services, 2002b). Additionally, under these requirements state
Medicaid agencies must contract with an External Quality Review Organization (EQRO)
to validate performance measures, performance improvement activities, and assess MCO
compliance with state contracts and federal regulations (Centers for Medicare &
Medicaid Services, 2003). In addition, Medicaid agencies can utilize EQROs to conduct
“optional activities” such as focused studies, providing technical assistance related to
improvement in a specific area, and producing annual reports on their evaluations. To
qualify as an EQRO, an organization must at minimum meet the following requirements:
•

Competence: The EQRO must have staff with experience and knowledge
of Medicaid recipients, policies, processes; managed care delivery
systems; quality assessment and improvement methods; research design;
the physical, technical and financial resources to conduct EQR activities,
and competence to oversee the work of subcontractors.

•

Independence: The EQRO must be independent from the State Medicaid
Agency and the MCOs that they are reviewing. They cannot exert control,
or have any contractual relationships with the MCOs, nor can they deliver
any health care services to Medicaid recipients.

A recent study suggested that many states are not aware of or are not fully
utilizing EQROs to assist in the evaluation and improvement of the delivery of
developmental services to children (Ireys, Krissik, Verdier, & Melissa, 2005). Although
a majority of members enrolled in Medicaid managed care plans are children, the authors
found that in any given year, few states utilized their contracted EQRO to evaluate the
quality of preventive or developmental services for children. When studies were done,
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they generally calculated the rate or occurrence of EPSDT or well child visits, rather than
the content of these visits and whether or not preventive services or anticipatory guidance
are offered.
Among their recommendations, Ireys et al. (2005) suggest that it is important for
states to include standards for preventive and developmental services in their quality
strategy and managed care contracts and to incorporate requirements for improvement in
preventive or developmental services into mandatory performance improvement projects.
In addition, they suggest that it will be difficult for a single state agency to make progress
on improving the state wide provision of preventive or developmental services.
Therefore they recommend that states develop models and contractual requirements for
collaboration of multiple stakeholders, including the MCO and EQRO participants (Ireys
et al., 2005; Krissik et al., 2008). To be effective, such collaborative arrangements
should include other stakeholders, such as providers, members, public health
departments, and others involved in the provision of these services.
Noting studies that have found associations between the use of electronic medical
records (EMR) and improved quality of care, the authors suggest that a further avenue to
pursue is encouraging the adoption of EMR. This can assist in both documenting the
provision of developmental services, as well as providing cues or reminders for providers
as to the services that are due for a particular patient (Krissik et al., 2008).
Accreditation
An area not often discussed in the policy literature is establishing requirements for
accreditation to allow managed care organizations to participate in state Medicaid
programs. Accreditation by private organizations can provide independent attestation of
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a health plan’s adherence to specific quality standards. In addition, to avoid duplication
of activities federal regulations allow states to use information obtained from reviews by
a Medicare or private accrediting organizations to demonstrate compliance with
requirements for quality oversight of managed care plans (Centers for Medicare &
Medicaid Services, 2003).

States must specify in their quality strategy those specific

standards for which they will use the results of the private accreditation review to assess
compliance, and why these standards are duplicative with the federal and state standards.
The National Committee for Quality Assurance (NCQA) has developed a
crosswalk between its standards and federal Medicaid managed care requirements which
can be used by states as a guide to determining which review activities can be
streamlined by deeming them as equivalent to NCQA standards. According to the
NCQA, 25 states currently use NCQA accreditation, either as a requirement to participate
in their Medicaid program, or to assist in their external quality review by deeming NCQA
standards as equivalent to specific federal and state standards (Thurston Toppe & Love,
2009).
Summary of Recommendations for State Oversight
Policy experts have suggested a number of steps that Medicaid agencies can take
to bolster their efforts to improve access and quality of care for Medicaid recipients
receiving services through managed health care organizations. These recommendations
have focused on leveraging requirements from the BBA and the use of EQROs to
utilizing standard performance measures such as HEDIS and CAHPS and tying these to
value based purchasing strategies. Additional recommendations have focused on
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beginning to build in plans to use EMR as part of quality improvement strategies and to
utilize health collaboratives to address statewide improvements.
While some studies have looked at the evolution of Medicaid quality programs
over time (Landon & Epstein, 1999; Landon et al., 2004; Landon et al., 1998), there have
not been any recent studies that have evaluated the extent to which Medicaid agencies
have implemented a number of these different strategies and whether or not it is possible
to correlate these strategies with the ability to assess quality outcomes.
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III.

METHODS AND PROCEDURES

The present study utilized a standardized survey to query state Medicaid agencies
regarding their quality strategies, and the requirements related to quality improvement
that they have established for their managed care organizations. It assessed the degree to
which Medicaid agencies have adopted recommendations geared toward improving
quality by evaluating the extent to which state programs have:
1. Established performance measures based on national or standardized measures;
2. Implemented a process to report measures and other quality data publicly;
3. Targeted the reporting of public information toward different stakeholder groups:
a. Members;
b. Providers;
c. Legislators and other regulators;
d. Advocates;
4. Encouraged, required or utilized computerized health data;
5. Established value-based purchasing utilizing some form of reward for high
performing providers or health plans;
6. Established a regular process to coordinate multi-stakeholder collaboration
regarding quality improvement initiatives;
7. Established a process to evaluate the content and not just the rate of
developmental services; and
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8. Incorporated requirements for improvement in developmental and preventive
services into either their quality strategy, state plan, or MCO contracts
The study also considered whether there were specific measures being utilized by
a majority of Medicaid agencies which would allow national reporting of comparative
quality data.
Survey Instrument
A seventy-six item tool was developed to survey Medicaid agency staff on
various quality measures and strategies that they have adopted as part of their managed
care programs (Appendix A). In an effort to increase response rates, the survey was
designed to allow for quick and efficient input by the respondent. To increase the
standardization of the responses, the majority of questions were designed to require
structured input, such as endorsing the specific quality improvement tools that were used
by the agency. The survey was designed as a web-based tool that required user to follow
a link from an e-mail and select their responses by clicking their mouse. The tool utilized
skip logic such that a “No” response preceding a block of questions (such as “Does your
state require reporting of HEDIS measures?”) would skip all subsequent questions related
to that response. The purpose was to focus respondents’ time and attention on only those
areas relevant to their state and to minimize the response time to complete the survey.
Pre-testing of the tool using staff members from the Georgia Department of Community
Health indicated a time of approximately 15 minutes to answer all of the questions.
The survey instrument was administered through PsychDataTM
(www.psychdata.com), an internet based survey tool that has been developed specifically
for social sciences research. PsychDataTM was chosen because it is specifically designed
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for academic research and has a number of safeguards to ensure the security and
confidentiality of data, including encrypted data transmission, password protected data,
and a secure survey environment which does not store any session data on the user’s
computer. In addition, PsychDataTM allows direct export of data into SPSS, which
streamlined the process of creating the data file for analysis.
The survey instrument was divided into sections that asked respondents questions
on:
•

Their managed care program and populations that were covered;

•

Oversight of EPSDT services;

•

Requirements for Performance Improvement Projects;

•

The types of Performance Measures required, and ways that they were used to
assess quality; and

•

Initiatives focused on Public Reporting, Value Based Purchasing, and
Electronic Health Data.

The investigators considered asking more detailed questions regarding the dates
that specific quality initiatives were started and stopped, along with trended performance
data or HEDIS data. While this would have potentially allowed for an assessment of
which specific quality initiative were associated with specific improvements in quality,
this information was not requested as part of this study. It was felt that the level of detail
required to respond would have discouraged Medicaid staff from participating. Further,
it was unlikely that an adequate sample size would have been generated to have sufficient
statistical power to draw definitive conclusions. Although quantitative data on
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improvement was not collected, a subjective assessment was taken by asking respondents
to indicate whether or not any improvement had occurred on specific performance
measures over the past three years.
Survey Distribution
A list of the Medicaid Directors for all 50 states was compiled from a membership
listing of the National Association of State Medicaid Directors (NASMD). A cover letter
describing the purpose of the study and requesting participation was sent by e-mail to the
Medicaid Directors of all 50 states by the Quality Director of the Georgia Department of
Community Health (Appendix B). The e-mailed letter contained a direct link to the
survey instrument. Directors were asked to have the staff member most familiar with the
managed care quality program complete the survey. We received five automated
responses that the original e-mail was not received, either because of an invalid address,
or because the Medicaid Director for that state had retired. In each of these cases, the
correct contact address was identified, either through a search of the agency website or by
a phone call to the agency, and the e-mailed letter was successfully delivered.
States that did not respond within two weeks were sent a reminder message by the
study investigator requesting that they complete the survey within the next week. A
third reminder was sent to states that had still not responded after the end of the third
week.
A few states requested that a hard copy of the survey questions be sent to them so
that they could distribute the questions to different content experts, compile the
responses, and then submit their answers to the on-line survey tool. A print copy of the
survey questions was e-mailed to those states that requested it.
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Data Analysis
Survey data was downloaded into SPSS for analysis. Data was analyzed for only
those Medicaid agencies that reported that they had risk-based managed care programs.
The analysis included descriptive data as to the number and percentage of state Medicaid
agencies utilizing each of the different measures and strategies described above.
A number of the survey questions allowed respondents to select multiple
responses. For example, the question “Which populations are included in your risk based
managed care program?” allowed respondents to as few or as many of the listed
populations that applied. For these questions a multiple response analysis was used
which calculated the percentage of all possible responses for each question. In a single
response question which allows respondents to select only one answer, the number of
responses will not exceed the number of respondents. Thus, 50 states responding to a
question with four possible choices would yield up to 50 responses. In a multiple
response question, 50 states responding to a question with four possible choices could
yield up to 200 responses (each of 50 states selecting all four choices). The multiple
response analysis used in this study produced two statistics, Percent and Percent of
Cases. Percent reflects the percentage a response is selected relative to the total number
of responses; the cumulative Percent should not exceed 100. The Percent of Cases
reflects the percentage of respondents (States) that selected a particular response; the
cumulative Percent of Cases can exceed 100 since each state can select more than one
response. In this study Percent of Cases was the statistic of interest as the study
objective was to assess the percentage of states that are using specific quality tools and
measures. Therefore the Percent of responses is not displayed in the results tables.
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In addition to descriptive data, a crosstabs analysis was conducted to assess the
relationship between the use of pay for performance incentives, performance
improvement projects and self-reported improvements in quality. The survey asked
states that used HEDIS measures as performance measures to indicate 1) which of 35
HEDIS measures were reported to the state, and of these, which ones 2) were the focus of
a P4P incentive, 3) were the focus of a PIP, and 4) demonstrated improvement over the
past three years. There were 21 states that responded to this section of the survey, and 35
HEDIS measures. This resulted in a potential of 735 observations for each of the four
variables listed above. Because a state would only be able to know if improvement had
occurred if the specific measure was reported, the analysis only included HEDIS
measures that the state indicated were being reported to them. This resulted in a total of
329 observations for the variables 1) Focus of P4P incentive; 2) Focus of PIP; and 3) was
improvement demonstrated. To determine whether either P4P incentives or PIPs were
associated with improvements in quality, a crosstab analysis was computed between each
variable and the variable Improvement demonstrated.

IV.

RESULTS

A total of 31 states responded to the survey; of these, 24 (77%) reported that they
currently had contracts with risk-based managed care programs for their Medicaid
recipients; 7 (23%) indicated that they had no risk-based managed care contracts. Of the
24 states reporting that they had managed care programs, one did not respond to any
additional questions, thus there were 23 valid responses from state Medicaid agencies
with risk based managed care programs. A 2008 report on managed care in Medicaid by
the Office of the Inspector General (Office of the Inspector General, 2008) identified 37
states with risk based managed care programs. Thus the responses for this study reflect
62% of the states with risk based managed care programs.
The states responding indicated that they had managed care programs in place for
an average of 16.30 years, with a range of 3 years to 37 years. Eighty-two percent (82%)
reported that their managed care programs had been in effect for 10 or more years.
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Table 1 – Implementation of Managed Care Program

Using a multiple-response format (meaning that respondents could endorse a
single or multiple selections), states were asked to report on which populations were
enrolled in managed care programs. All of the states indicated that their programs
included low income children and pregnant women. In addition, 78% reported that they
included their SSI populations and 61% reported that they included their medically needy
populations and members that were in foster care. Less than 40% reported including
members covered because they were eligible for both Medicaid and Medicare, or because
they had breast or cervical cancer.
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Table 2 – Managed Care Populations
N
Managed Care Populations

Percent of Cases

Low income children

23

100.0%

Pregnant women

23

100.0%

Medically needy

14

60.9%

SSI

18

78.3%

Dual eligible

9

39.1%

Breast and Cervical Cancer

9

39.1%

14

60.9%

5

21.7%

Foster Care
Other (Please specify)

Although public health providers have traditionally served as safety net providers
for low-income, uninsured, and Medicaid patients, 32% of the states reported that public
health providers were not covered by their MCOs. The states were approximately evenly
divided on their report as to whether their quality programs has oversight over only their
managed care programs (48%), or over both their managed care and their fee-for-service
programs (52%).
Performance Improvement Projects
Performance Improvement Projects (PIPs) are required by the BBA and are one of
the methods policy experts recommend that states use to emphasize improvements in
quality. While Medicaid agencies may allow each of their contracted MCOs to choose
PIPs that they believe are relevant for their membership, one of the ways that states can
direct efforts to improve quality is to specify specific areas that PIPs should address.
The number of reported PIPs required by states varied from one to eight, with an
average of 2.32 per state. Eighty-one percent of the states require three or fewer PIPs,
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and there was only one state that required more than four. A total of 19 of 22 states
(86%) stated that they specify specific areas that their MCOs must address with their
PIPs. As shown in Table 3, the most frequently addressed area was childhood
immunizations (58%), followed by well child visits (47%), and child chronic conditions
(32%). Few states required PIPs to focus on dental services (21%), or access to care
(21%). Two states (9%) required PIPs focused on childhood obesity, and only one
reported requirements to address prenatal care.
Some researchers have suggested that utilizing collaborative improvement
projects, in which various payers, providers, etc. coordinate together to improve care, can
be more effective that having each MCO embark on their own improvement project.
Sixteen of 23 states (70%) reported that they require that their MCO conduct one or more
PIPs in collaboration with other organizations. Well-child visits were most often the
focus of a collaborative PIP, required by five states (31%). This was followed by child
immunizations (25%), adult chronic conditions (25%), and child chronic conditions
(19%) (see Table 4). In most cases the oversight and coordination of the collaborative
PIP has been conducted by state Medicaid agency staff (87% of states) (see Table 5).
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Table 3 – Required Performance Improvement Projects
N
Required PIP Areas

Percent of Cases

Well Child Visits

9

47.4%

Immunizations

11

57.9%

Dental services

4

21.1%

Child chronic conditions

6

31.6%

Adult chronic conditions

2

10.5%

Access to care

4

21.1%

Member or provider

3

15.8%

13

68.4%

satisfaction
Other (Please specify)

Table 4 - Focus of Collaborative PIP
Focus of Collaborative PIP – Multiple Response Frequencies
N
Collaborative PIPs

Percent of Cases

Well Child Visits

5

31.3%

Immunizations

4

25.0%

Dental services

2

12.5%

Child chronic conditions

3

18.8%

Adult chronic conditions

4

25.0%

Access to care

2

12.5%

Member or provider

1

6.3%

8

50.0%

satisfaction
Other (Please specify)
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Table 5 - Coordination of Collaborative PIP
N
Who Coordinates
Collaborative PIP

Percent of Cases

Medicaid staff

14

87.5%

EQRO vendor

5

31.3%

Academic Institution

1

6.3%

Other (Please specify)

5

31.3%

Incentives and Penalties
One method for states to encourage achieving specific quality goals is to align
financial incentives such that MCOs or provider are either rewarded for reaching these
goals, or penalized for failing to meet established goals. These may be monetary, in the
form of additional or higher payments, or may take some other form that is beneficial for
the MCO or provider. Only 14 states (61%) reported that they currently provide any
incentives or penalties that are specifically tied to quality goals; 13 of these states
specified the types of incentives they provided. The most common incentive provided
was a direct financial incentive to an MCO (85%), followed by public recognition for the
MCO (54%) and preferential auto-assignment of new members to an MCO (46%). State
reported that they were less likely to assess penalties or sanctions for failure to meet
quality goals, with 12 states (55%) reporting that they did so. Similar to incentives, the
most common penalty was monetary (67%), followed by loss of assignment of new
members (50%).
Of the 13 states that reported specific quality incentives, only two states (15%)
reported making direct incentive payments to providers. These two states, plus two
additional, reported that they required their MCOs to provide quality incentives to
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providers, while a total of 15 states (68%) reported that their MCOs were voluntarily
providing some form of quality incentives directly to providers. The type of provider
most likely to receive some form of incentive payment was a small primary care practice
(71% of states), followed by large outpatient groups (57%), and public health clinics
(36%).

Table 6 - Provider Incentives
Percent of
Cases

N
Provider Incentives

If yes, what provider groups are eligible to

3

21.4%

Large outpatient groups (IPAs, PHOs, etc)

8

57.1%

Small or individual primary care practices

10

71.4%

Public health clinics

5

35.7%

Other (Please specify)

3

21.4%

participate in the pay for performance
program?: Hospitals

Performance Measures
All of the states responding reported that they relied on the use of some type of
standardized performance measures to evaluate the quality of care and service delivered
to their members. Of these, 96% reported that they utilized HEDIS measures; the one
state that was not using HEDIS measures indicated that they were using “HEDIS-like”
measures. In addition to HEDIS measures a few states also reported using measures that
have been developed by CMS (17%) and the Agency for Healthcare Research and
Quality (AHRQ) (13%); two states reported the use of local, state-developed performance
measures (see Table 7).
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Table 7 – Use of Standardized Performance Measures
Standard Performance Measures - Multiple Response Frequencies
N
Standard Performance
Measures

HEDIS

Percent of Cases
22

95.7%

CMS

4

17.4%

AHRQ

3

13.0%

Other (Please specify)

9

39.1%

a

All but two states (91%) reported that they relied on non-standardized
performance measures to assess the quality of their programs. They indicated that these
measures were used most frequently to measure access to care (78%), followed by
utilization of services (70%) and provider networks (52%) (Table 8).

Table 8 – Use of Non-standard Performance Measures
N
Non Standard Performance
Measures

Percent of Cases

Provider networks

12

52.2%

Access to care

18

78.3%

Processes of care

9

39.1%

Health outcomes

9

39.1%

16

69.6%

2

8.7%

6

26.1%

Utilization of service
Do not use any non-standard
performance measures
Other (Please specify)

HEDIS Measures
One of the most consistently reported means of evaluating quality by the different
states was the use of HEDIS measures, with 96% reporting their use. States were asked

40
to indicate which of 35 HEDIS measures were 1) reported to the state; 2) the focus of a
pay-for-performance incentive; 3) the focus of a performance improvement project; and
4) whether any improvement had been demonstrated on this measure over the past three
years.
The measures most frequently utilized by states for assessing quality are
presented in Table 9. Given that all states responding reported including low income
children in their managed care populations, it is not surprising that the most frequently
used measures pertained to services delivered to, or relating to the health of children.
These included well visits for children and for adolescents, prenatal and postpartum care,
and childhood immunization status. Other frequently used measures that may relate to
children or adults included measures of appropriate medications for people with asthma,
comprehensive diabetes care, and member satisfaction. Although there has been much
recent concern related to the provision of dental services for Medicaid children (Centers
for Medicare & Medicaid Services, 2009), only 50% of the states reported using the
HEDIS measure Annual Dental Visit. A recent policy brief suggested that when
compared with privately insured children, children covered by Medicaid are more likely
to have untreated tooth decay and to be in need of urgent dental care. It also noted that
parents of publicly insured children identified dental care as the greatest unmet medical
need (Paradise, 2009).
Measures reflecting the quality of mental health services were not generally
reported, with only 30% of states indicating they report on a measure of follow-up after a
mental health hospitalization, and only 10% stating that they measure the follow-up care
for children prescribed ADHD medications.
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Table 9 – HEDIS Measures Reported to the State

Well-Child Visits in the
Third, Fourth, Fifth and
Sixth Years of Life

20

Percent of
Cases
100.0%

Well-Child Visits in the First
15 Months of Life

20

100.0%

Use of Appropriate
Medications for People With
Asthma

19

95.0%

N

Adolescent Well-Care Visits

18

90.0%

CAHPS Health Plan Survey
4.0H, Adult Version

18

90.0%

Prenatal and Postpartum
Care

17

85.0%

Childhood Immunization
Status

16

80.0%

Comprehensive Diabetes
Care

16

80.0%

CAHPS Health Plan Survey
3.0H, Child Version

16

80.0%

Cervical Cancer Screening

13

65.0%

Breast Cancer Screening

13

65.0%

Children's and Adolescents'
Access to Primary Care
Practitioners

12

60.0%

Adults' Access to
Preventive/Ambulatory
Health Services

11

55.0%

Frequency of Ongoing
Prenatal Care

10

50.0%

Annual Dental Visit

10

50.0%

Lead Screening in Children

9

45.0%

Controlling High Blood
Pressure

8

40.0%

Cholesterol Management
for Patients With
Cardiovascular Conditions

8

40.0%

Chlamydia Screening in
Women

8

40.0%

Appropriate Testing for
Children With Pharyngitis

8

40.0%

Appropriate Treatment for
Children With Upper
Respiratory Infection

8

40.0%

Children With Chronic
Conditions

8

40.0%

Follow-Up After
Hospitalization for Mental
Illness

6

30.0%

Medical Assistance With
Smoking Cessation

6

30.0%

Antidepressant Medication
Management

5

25.0%
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Annual Monitoring for
Patients on Persistent
Medications

4

Percent of
Cases
20.0%

Avoidance of Antibiotic
Treatment in Adults With
Acute Bronchitis

4

20.0%

Beta-Blocker Treatment
After a Heart Attack

4

20.0%

Persistence of Beta-Blocker
Treatment After a Heart
Attack

3

15.0%

Use of Imaging Studies for
Low Back Pain

3

15.0%

Disease Modifying AntiRheumatic Drug Therapy
for Rheumatoid Arthritis

2

10.0%

Follow-Up Care for Children
Prescribed ADHD
Medication

2

10.0%

Use of Spirometry Testing
in the Assessment and
Diagnosis of COPD

2

10.0%

Pharmacotherapy of COPD
Exacerbation

1

5.0%

Initiation and Engagement
of Alcohol and Other Drug
Dependence Treatment

1

0

N

With regard to efforts to improve quality as reflected by these measures,
Childhood Immunization Status was the measure that was most frequently the focus of a
pay for performance incentive (82%), and most frequently reported to be included in a
performance improvement project (60%), as well as the measure most frequently cited as
having shown improvement (92%). Of 21 states that reported that they utilized HEDIS
measures to assess quality of care, 20 states (95%) reported that they had HEDIS
measures reported to them by their MCOs, 15 (71%) indicated that they were the focus of
a PIP, and only 11 (52%) reported that they were utilizing them as part of a pay for
performance incentive. Thirteen states (62%) reported that they had observed some
improvement on theses measures over the past three years (Table 11).
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Table 10 – Use of HEDIS Measures for Quality Improvement
Report HEDIS

HEDIS Measure
Reported to State

Valid

Yes

Frequency
20

No
Total
Missing

System

Valid
Percent
95.2

1

4.8

21

100.0

2

Total

23

HEDIS PIP

Focus of PIP

Valid

Yes

Frequency
15

Valid
Percent
71.4

6

28.6

21

100.0

No
Total
Missing

System

2

Total

23

HEDIS P4P

Focus of P4P

Valid

Missing

Yes

Frequency
11

Valid
Percent
52.4

No

10

47.6

Total

21

100.0

System

2

Total

23

HEDIS Improvement

Reported Improvement

Valid

Yes
No
Total

Missing
Total

System

Frequency
13

Valid
Percent
61.9

8

38.1

21

100.0

2
23
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Table 11 – HEDIS Measures – Strategies for Improvement
P4P

PIP

Childhood Immunization
Status

9

Percent of
Cases
81.8%

Adolescent Well-Care Visits

7

Well-Child Visits in the
Third, Fourth, Fifth and
Sixth Years of Life

Improvement

9

Percent of
Cases
60.0%

12

Percent of
Cases
92.3%

63.6%

6

40.0%

9

69.2%

6

54.5%

4

26.7%

10

76.9%

Use of Appropriate
Medications for People With
Asthma

6

54.5%

6

40.0%

9

69.2%

Prenatal and Postpartum
Care

6

54.5%

2

13.3%

9

69.2%

Comprehensive Diabetes
Care

6

54.5%

4

26.7%

8

61.5%

N

N

N

Cervical Cancer Screening

6

54.5%

1

6.7%

5

38.5%

Lead Screening in Children

6

54.5%

3

20.0%

7

53.8%

Well-Child Visits in the First
15 Months of Life

5

45.5%

3

20.0%

11

84.6%

Frequency of Ongoing
Prenatal Care

4

36.4%

1

6.7%

5

38.5%

Controlling High Blood
Pressure

4

36.4%

2

15.4%

CAHPS Health Plan Survey
4.0H, Adult Version

3

27.3%

1

6.7%

4

30.8%

Breast Cancer Screening

3

27.3%

1

6.7%

4

30.8%

Children's and Adolescents'
Access to Primary Care
Practitioners

3

27.3%

2

13.3%

7

53.8%

Annual Dental Visit

3

27.3%

3

20.0%

5

38.5%

Cholesterol Management
for Patients With
Cardiovascular Conditions

3

27.3%

3

23.1%

CAHPS Health Plan Survey
3.0H, Child Version

2

18.2%

1

6.7%

4

30.8%

Adults' Access to
Preventive/Ambulatory
Health Services

2

18.2%

1

6.7%

4

30.8%

Chlamydia Screening in
Women

2

18.2%

2

15.4%

Follow-Up After
Hospitalization for Mental
Illness

2

18.2%

1

7.7%

Appropriate Testing for
Children With Pharyngitis

1

9.1%

3

23.1%

Appropriate Treatment for
Children With Upper
Respiratory Infection

1

9.1%

1

6.7%

4

30.8%

Children With Chronic
Conditions

1

9.1%

1

6.7%

3

23.1%
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P4P

PIP

Medical Assistance With
Smoking Cessation

1

Percent of
Cases
9.1%

Antidepressant Medication
Management

1

9.1%

Annual Monitoring for
Patients on Persistent
Medications

1

9.1%

Persistence of Beta-Blocker
Treatment After a Heart
Attack

1

9.1%

Use of Imaging Studies for
Low Back Pain

1

Disease Modifying AntiRheumatic Drug Therapy
for Rheumatoid Arthritis
Follow-Up Care for Children
Prescribed ADHD
Medication

Improvement

1

Percent of
Cases
7.7%

1

7.7%

9.1%

1

7.7%

1

9.1%

1

7.7%

1

9.1%

N

Percent of
Cases

N

N

1

6.7%

1

7.7%

1

6.7%

1

7.7%

1

0

Avoidance of Antibiotic
Treatment in Adults With
Acute Bronchitis
Beta-Blocker Treatment
After a Heart Attack
Use of Spirometry Testing
in the Assessment and
Diagnosis of COPD
Pharmacotherapy of COPD
Exacerbation
Initiation and Engagement
of Alcohol and Other Drug
Dependence Treatment

Totals

98

52

138
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Table 12 – Number of HEDIS Measures Reported to Medicaid Agencies
No. of HEDIS Measures
Number of
Number of
Measures
Reported
Valid

Missing
Total

States

Cumulative

Frequency

Percent

Valid Percent

Percent

.00

1

4.3

4.8

4.8

7.00

1

4.3

4.8

9.5

9.00

1

4.3

4.8

14.3

11.00

2

8.7

9.5

23.8

12.00

1

4.3

4.8

28.6

13.00

2

8.7

9.5

38.1

14.00

2

8.7

9.5

47.6

15.00

1

4.3

4.8

52.4

16.00

2

8.7

9.5

61.9

18.00

1

4.3

4.8

66.7

19.00

1

4.3

4.8

71.4

20.00

2

8.7

9.5

81.0

21.00

2

8.7

9.5

90.5

29.00

1

4.3

4.8

95.2

30.00

1

4.3

4.8

100.0

Total

21

91.3

100.0

2

8.7

23

100.0

System
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Table 13 – Number of Pay for Performance Incentives
Number of P4P Incentives
Number of
P4P
Incentives

Number of
States

Cumulative

Frequency
Valid

Missing

Percent

Valid Percent

Percent

.00

10

43.5

47.6

47.6

1.00

1

4.3

4.8

52.4

3.00

1

4.3

4.8

57.1

4.00

2

8.7

9.5

66.7

5.00

1

4.3

4.8

71.4

6.00

1

4.3

4.8

76.2

8.00

1

4.3

4.8

81.0

11.00

1

4.3

4.8

85.7

15.00

1

4.3

4.8

90.5

17.00

1

4.3

4.8

95.2
100.0

24.00

1

4.3

4.8

Total

21

91.3

100.0

2

8.7

23

100.0

System

Total

Table 14 – Number of Performance Improvement Projects
Number of PIPs
Number of
PIPs

Number of
States

Cumulative

Frequency
Valid

Missing
Total

Percent

Valid Percent

Percent

.00

6

23.1

28.6

28.6

1.00

4

17.4

19.0

47.6

2.00

1

4.3

4.8

52.4

3.00

3

13.0

14.3

66.7

4.00

2

8.7

9.5

76.2

5.00

3

13.0

14.3

90.5

6.00

1

4.3

4.8

95.2

8.00

1

4.3

4.8

100.0

Total

21

91.3

100.0

2

8.7

23

100.0

System

48
To assess the degree to which PIPs or P4P incentives may be related to reported
improvement in HEDIS measures, a crosstabs analysis was computed combining data
from all 21 states that responded to this set of questions and all 35 HEDIS measures.
This resulted in 735 potential observations for each of the three variables: whether a PIP
was conducted; whether a P4P incentive was in place; and whether any improvement was
reported by the state Medicaid agency. Eliminating observations for HEDIS measures
that were not reported to the state resulted in a total of 329 observations. When no P4P
incentive was in place, improvement was demonstrated in only 31.4% of the cases, as
opposed to 68.8% of the cases when a P4P incentive was in place. Thus, having a PIP in
place was significantly associated with a reported improvement in performance Χ2=38.4,
p<.001 (see Table 15).

Table 15 - Crosstabs: P4P & Improvement
P4P Incentive *Improvement Demonstrated Crosstabulation
Improvement Demonstrated

P4P Incentive

P4P Incentive Unchecked
P4P Incentive Checked

Total

Count
% P4P Incentive
Count
% P4P Incentive
Count

Improvement

Improvement

Demonstrated -

Demonstrated -

Unchecked

Checked

Total

162

74

236

68.6%

31.4%

100.0%

29

64

93

31.2%

68.8%

100.0%

191

138

329
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Chi-Square Tests

Value

df

Asymp. Sig. (2-

Exact Sig.

Exact Sig.

sided)

(2-sided)

(1-sided)

38.445a

1

.000

Continuity Correctionb

36.922

1

.000

Likelihood Ratio

38.546

1

.000

Pearson Chi-Square

Fisher's Exact Test

.000

Linear-by-Linear Association
N of Valid Cases

38.328

1

.000

.000

329

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 39.01.
b. Computed only for a 2x2 table

Similarly a having a PIP was also associated with improved performance. When
there was no PIP associated with a HEDIS measure, improved occurred in 37.8% of the
cases, as opposed to 64.7% of the cases with a PIP. This association was also significant,
Χ2=12.8, P<.001 (see Table 16).

Table 16 - Crosstabs: PIP & Improvement
Focus of PIP * Improvement Demonstrated Crosstabulation
Improvement Demonstrated

Focus of PIP

Focus of PIP - Unchecked Count
% within PIP
Focus of PIP - Checked

Count
% within PIP

Total

Count

Improvement

Improvement

Demonstrated -

Demonstrated -

Unchecked

Checked

Total

173

105

278

62.2%

37.8%

100.0%

18

33

51

35.3%

64.7%

100.0%

191

138

329
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Chi-Square Tests

Value

df

Asymp. Sig.

Exact Sig.

Exact Sig.

(2-sided)

(2-sided)

(1-sided)

12.840a

1

.000

Continuity Correctionb

11.758

1

.001

Likelihood Ratio

12.705

1

.000

Pearson Chi-Square

Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases

.001
12.801

1

.000

.000

329

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 21.39.
b. Computed only for a 2x2 table

Public Reporting
As noted by Verdier & Hurley (2004), public reporting of quality data can be
important in providing a level of transparency regarding efforts to improve quality,
engaging stakeholders by providing data and feedback on the results of quality initiatives,
and encouraging competition between MCOs and providers to improve performance on
quality measures. Most states (87%) indicated that they do report at least some of their
quality data publicly. The most common method of reporting is this information was
through an annual report posted on a web-site (85%). Slightly less than half the states
reported posting information on a health transparency website (45%) or producing a hard
copy report (40%).
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Table 17 - Methods of Public Reporting of Data
N
Public Reporting of
Data

Annual Report (web based)

Percent of Cases
17

85.0%

Annual Report (paper or hard copy)

8

40.0%

Transparency or health information

9

45.0%

2

10.0%

website
Other

Although it has been recommended that Medicaid agencies tailor the reporting of
public data to the specific target audience, only 5 states (25%) indicated that they did this.
Electronic Health Records
A significant proportion of states (68%) reported having some initiative to
increase the use of electronic health records. Some of these projects were reported to be
funded through CMS Medicaid transformation grants and others through state grants.
Initiatives were focused across of range of provider types, including inpatient and
outpatient. Some focused specifically on assisting providers in adopting electronic health
records, while others described initiatives to link providers electronically to a central
database that tracked the provision of services from claim or prescription data. Only four
states reported using any electronic health data to capture quality measures, those that
did, described obtaining data from immunization registries, or electronically transmitting
claim data to calculate HEDIS measures.
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Preventive/Developmental Services (EPSDT)
With all of the states responding indicating that low-income children were
included in their managed care programs, assessment of the quality of developmental
services should be a significant component. States were asked a variety of questions as to
how they evaluated the quality of developmental services (or services provided under
EPSDT regulations). A majority of states (82%) reported that they did have specific
provisions regarding the evaluation of developmental services. Of these, the majority
indicated that these provisions were specified directly in their managed care contracts
(89.5%), followed by the state quality strategy (42%), the state plan (32%), and EQRO
contracts (26%).

Table 18 – Provisions for Evaluation of Developmental Services
N
Defined Provisions for EPSDT

Percent of Cases

State Plan

6

31.6%

State Quality Strategy

8

42.1%

17

89.5%

EQRO Contracts

5

26.3%

Other (Please specify)

3

15.8%

MCO Contracts

States reported that the quality of developmental services is primarily assessed
through an evaluation of performance measures (84%), while about half also utilize
medical record reviews (52%) and four states indicated that they assessed services either
through member surveys or focus groups (21%). None of the states reported using
surveys designed specifically for assessing developmental services, such as the
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Promotion of Healthy Development Survey (PHDS), or the Young Adult Health Care
Survey (YAHCS).

Table 19 – Methods Used to Assess Developmental Services
N
Assess Developmental Services Performance Data
Medical Record Review
Focus groups or surveys of

Percent of Cases
16

84.2%

10

52.6%

4

21.1%

7

36.8%

members
Other (Please specify)

States generally reported relying on Medicaid (74%) or MCO (74%) staff to
conduct the evaluation of developmental services. Fewer states reported that they relied
on their EQRO vendor (42%) to conduct these assessments. While use of MCO staff to
evaluate the provision of developmental services generally was coupled with the use of
Medicaid or EQRO staff reviews, in one state the only method consisted of MCO
medical record reviews.

V.

DISCUSSION AND CONCLUSION

This study sought to evaluate the approaches that state Medicaid agencies are
taking to monitor and improve the quality of care delivered to recipients covered under
their managed care programs. The results of this study indicate that state Medicaid
agencies have adopted a number of the recommendations that have been made by policy
researchers and that there has been greater adoption of standard performance measures
across states. Public reporting of quality data appears to be increasing, but it does not
appear that most states specifically target the type of information reported to a specific
audience.
A number of policy experts (Corrigan et al., 2002; Ramirez de Arellano & Wolfe,
2007) have stressed the need for state Medicaid agencies to use standardized measures to
assess quality, and to allow comparative assessments of quality across states to occur.
The findings of this study suggest that this is happening, with all but one of the states
with managed care programs stating that they utilize HEDIS measures as one of their
methods to assess quality (the one state reporting that they did not use HEDIS indicated
that they use HEDIS like measures and are planning to move to standard HEDIS
measures in the future). While none of the states reported using all available HEDIS
measures, there are a number of common measures that are currently being utilized by a
majority of states. The measures that were used most consistently were those for
evaluating the utilization of well visits for both children and adolescents; the use of
appropriate medications for people with asthma; the timeliness of prenatal and
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postpartum care; childhood immunization status; comprehensive diabetes care; and
member satisfaction surveys of both children and adults. These measures were used by
80% or more of the states responding to this survey and are relevant to the population of
low income children and pregnant women who are included in every state’s managed
care program. Over 95% of the Medicaid agencies reported that they would find it
moderately or extremely useful to have a central site for reporting Medicaid quality
measures. The common use of these measures across states would make it relatively easy
to introduce them as a core set of measures that all state Medicaid agencies would report,
allowing for the possibility of comparative analysis of different Medicaid programs.
Additional measures that are relevant (such as use of dental services, or mental health
measures) could be added to the core set over time. Other measures that may be relevant
for specific populations, such as pharmacotherapy for COPD patients, could be
established as optional measures to be utilized by states targeting those conditions.
Most Medicaid agencies report using their contracting authority to emphasize
areas for quality improvement, with 86% indicating that they delineate specific areas that
must be addressed by PIPs. The findings from this study suggest that implementing PIPs
are associated with improvements in performance measures, with improvement noted on
64.7% of HEDIS measures that were associated with PIPs, as opposed to 37.8% of those
measures not associated with a PIP. Additionally, a majority of states (70%) have
adopted practices that are in line with recommendations that PIPs be done
collaboratively (Gold et al., 2006; Ireys et al., 2005; Krissik et al., 2008). Ireys et al
(2005) voiced concerns that state agencies alone would find it difficult to drive major
improvements in quality, and that true improvement would require collaborative efforts
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by a number of stakeholders, including MCOs, providers, members, and community
organizations. Although many states do require collaborative improvement projects, a
majority are also relying on their own staff to coordinate these activities. With tightening
state budgets, a concern is that agency staff may be pulled in multiple directions and find
that they are not able to devote the resources necessary to keep a collaborative
improvement project moving. Ireys et al (2005) suggest that utilizing EQRO contracts to
oversee collaborative projects may be a more viable alternative, though one that not many
states appear to be using at the present time.
Public reporting, value based purchasing, and adoption of health information
technology have all been receiving much attention as promising strategies to further
improve the quality of health care. The data from this study indicate that state Medicaid
agencies are moving toward utilizing these strategies, though they have not yet adopted
them as fully as reporting of performance measures and implementation of performance
improvement projects. At this point, of the three areas, public reporting of data has been
most consistently adopted, with 87% of the states responding indicating that they report
their quality data publicly in some form. The data suggests that for most states, public
reporting has taken the form of an annual report that is posted to a web site (in many
cases this appears to be the EQRO evaluation). Few states have adopted
recommendations to report comparative data targeted to the interests and understanding
of different stakeholders. While the level of detail in most evaluative reports is helpful to
health care professionals, it may not address the specific questions that legislators may
have related to questions such as the cost-effectiveness of programs, or help members
make determinations as to which health plan they would like to select. The use of reports
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and information that is targeted toward specific stakeholders will be more likely to
continually drive quality performance toward further improvements, however, it also
requires more resources to determine the information that different stakeholders want and
then formatting information differently for their use.
Value based purchasing (using either incentives or sanctions) has been utilized
less than public reporting. Although the Institute of Medicine (2001) has stressed the
need to align payment strategies with desired improvements in quality, only 61%
currently report having taken this step. The strategies of public reporting and pay for
performance both require the development of valid and reliable performance measures.
In addition, pay for performance programs may also require the procurement of
additional funds (which may be difficult for many state agencies). In fact, a recent
survey of state Medicaid directors indicated that the current economic conditions were
leading to cutbacks in Medicaid programs, including P4P incentives (Smith et al., 2009)
The findings of this study suggest that P4P incentives, as well as PIPs are
associated with improvements in performance. States reported improvement on 68.8% of
HEDIS measures when P4P incentives were utilized, as compared with 31.4% when they
were not. While the self-report nature of this study design limits the strength of this
conclusion, other studies have also suggested positive impact with P4P incentives.
Felt-Lisk et al (2007) suggest that it is important for incentives to be sufficiently large to
be perceived as a reward by the target of the incentive (health plans, providers). They
also must be carefully designed to assure that they are rewarding the desired behavior and
minimizing potential unintended consequences, such as having providers or health plans
avoid sicker patients. A possible strategy to address this would be to broadening pay for
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performance incentives from paying to meet a specific performance goal to also
providing incentives for adopting practices that have been shown to improve general
health outcomes, such as becoming a patient’s medical home (i.e., rewarding
improvements in both process and outcomes).
In addition to providing incentives, 55% of the states reported that they also
assess penalties for MCOs that fail to meet quality goals. There is little empirical
literature examining the differential effect of incentives versus penalties on performance.
Conrad and Perry (2009) in a review of the literature, found only two studies that
included both incentives and rewards in their evaluation. The first study, evaluating a
CMS P4P program with hospitals was not yet completed. A second study that found
significant improvement in diabetes care processes based on a program combining
incentives and withholds was not designed to differentiate the effects of incentives versus
penalties. They suggest that both rewards and penalties have their place in value based
purchasing, and theorize that penalties may have a greater effect, based on economic
theory of risk aversion that postulates that individuals assign greater weight to potential
losses than potential gains (Conrad & Perry, 2009; Weimer & Vining, 2005). This will
be an area for further research to evaluate.
Widespread use of electronic health records (EHR) will allow standard
performance measures to move beyond data based largely on claim data reflecting the
occurrence of a service or procedure. Electronic records will allow for more efficient
capturing of data that reflects both the treatments that are being used and the clinical
response to these treatments, allowing a truer picture of whether outcomes are improving
as a result of quality improvements efforts. Additionally, the use of EHR also can
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facilitate actual improvements in quality by providing additional tools for providers (in
terms of reminders of patient care that is due, alerts related to potential drug interactions,
and sharing of pertinent medical information between providers to improve care
coordination), as well as creating more opportunities to engage patients in their own care
through patient portals.
Several states are beginning to support providers in adopting electronic health
records, both through CMS Medicaid transformation grants, as well as state grants. This
support will likely accelerate over the next few years with further incentives that are
provided through the recent American Recovery and Reinvestment Act of 2009 (ARRA)
("American Recovery and Reinvestment Act of 2009,"). The ARRA provides $17.2
billion in incentives through Medicaid and Medicare payments, to assist providers in
adopting EHRs. This includes incentive payments, beginning in 2011, for providers that
are able to demonstrate “meaningful use” of certified EHR technology. While
“meaningful use” has not been fully defined yet, the provisions describe a meaningful
user as one who, uses the technology for such clinical tasks as electronic prescribing;
demonstrates the electronic exchange of information in such a way as to promote care
coordination; and submits data on clinical quality measures (Healthcare Information and
Management Society, 2009). Given the degree to which the population of Medicaid
beneficiaries lags behind commercially insured patients in many preventive and care
management measures, it will be important the Medicaid officials advocate for a
definition of meaningful user that addresses these deficits. This may include using the
EHR to facilitate the tracking and delivery of preventive services for individual patients,
as well as allowing and encouraging physicians to track the delivery of these services for
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their population of patients (such as the percentage of their patients that are up to date
with their immunizations, or the percentage of asthmatic children maintained on
appropriate medication). These elements of a “meaningful user” if realized, should
support improvements in both the delivery and measurement of quality care.
Although all states include children in their managed care populations, it appears
that only a few states have implemented many of the recommendations made by Ireys et
al (2005) regarding the provision of developmental services. While most states indicated
that they have included provisions for improving the quality of developmental services in
their MCO contracts, state plan, quality strategy, or EQRO contracts, few reported
actually evaluating the content of developmental screening visits as suggested by Ireys et
al (2005). It is likely that one of the major limitations for most states in this regard are
the resources required to either conduct medical record reviews, or surveys of patients
regarding the specific services that they have received.
Of concern is the fact that only 68% of the states indicated that public health
providers were covered by their managed care organizations. In addition, of states that
had P4P incentives, only 36% made them available to public health providers, as opposed
to 71% that included primary care providers. Given that public health providers have
served as a traditional safety net for individuals with low-incomes or no insurance, the
inability to utilize these providers under Medicaid managed care programs could result in
disruptions in the continuity of care. Indeed, several studies have suggested the public
health providers have fared poorly under a shift to managed care (Boehm, 2005; Louise,
2005; Willging, Waitzkin, & Nicdao, 2008). However, a recent survey suggested that
despite initial difficulties safety net providers encountered with managed care, many had
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managed to adapt to these changes (Lewin & Baxter, 2007). This survey suggests that
further study is required as to how public health providers fare under managed care
arrangements, as well as changes that may be necessary for them to compete with private
providers while continuing to serve those patients that are most vulnerable and lack other
resources to access care. Additionally it will be important to determine the impact that
public health providers have on access, continuity of care, and quality.
Limitations
The current study utilized a structured internet based survey to collect data on
state Medicaid agencies approaches to quality improvement. While this had the
advantage of standardizing the data across all states, it did not allow for the richness of
data that would have been possible through direct interviews with Medicaid agency staff.
Additionally the number of questions asked was limited to keep the time required to
respond low with the goal of increasing the response rate. The goal was to provide a
broad view of the approaches that state Medicaid agencies are taking to improve quality.
However, more detailed nuances as to how different Medicaid agencies implemented
these strategies, such as collaborative PIPs, or P4P programs, cannot be described. For
example, while the data indicated that 70% of state Medicaid agencies require one or
more collaborative PIPs, this data does not tell us more about the extent or the success of
the collaboration. It could be instructive to know who participated in collaborative
activity (e.g., other MCOs, other state agencies, public health organizations, community
organizations, providers, etc)., what strategies were successful in recruiting and
sustaining the engagement of other stakeholders as well as the activity itself, sources of
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funding activities, and which strategies were associated with improvements in care and
outcomes.
This study was prone to several limitations that are common to the use of selfreport survey data. It is possible that a positive response bias existed, with respondents
endorsing items that would present their agency in the most positive light. Although
most of the questions relied on terminology that is common to the Medicaid program, it is
possible that the interpretation of some questions may have varied with each respondent,
thus a collaborative PIP may have meant different things to different states. The survey
instructions also requested that responses come from the person “most knowledgeable
about your Medicaid quality program.” However, it is possible that this person may not
have been the content expert for all of the areas evaluated in this study. In fact, some
states requested a hard copy of the survey questions so that they could be reviewed and
answered by several people, each knowledgeable of different areas. Finally, evaluation
as to the degree to which different strategies or interventions were actually implemented
in any of the states was beyond the scope of this study. However, the range and extent to
which P4P incentives or performance improvement activities are implemented surely
varies from one state to another and this variance will impact their effectiveness in
improving quality.
Detailed questions regarding performance measures focused primarily on HEDIS
measures as this is one of the most common measure sets used within managed care
settings. However, there are a number of other standard performance measures, such as
those developed by the National Quality Foundation (NQF), and others, which may be
utilized by state Medicaid agencies but were not assessed as part of this study.
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Although respondents were asked about areas where improvements in quality had
occurred, it was beyond the scope of this study to evaluate whether any of the specific
strategies described were more effective than others in leading to improvement. To be
able to conduct this level of analysis would have required measuring the specific dates
that different strategies were implemented, and the collection of specific performance
measures over time. This would be a separate study, but one that will be important to
conduct. As Medicaid agencies cope with shrinking budgets and fewer resources one of
the crucial questions will be which strategies will be most cost effective in achieving
improvements in health care quality.
The study included responses from 23 of 37 states with risk based managed care
programs. While the sample included many larger states and many of those with
longstanding programs, and thus seems representative of the current state of quality
oversight in Medicaid managed care, a larger sample would have been preferred. Due to
a number of factors, the survey was distributed in January, a time when most states are
beginning their legislative sessions and placing much demand on state agencies. Thus the
timing of the survey distribution may have limited the number of responses that were
received.
Suggestions for Future Research
The current study provides a broad overview of the types of activities that state
Medicaid agencies are doing to assess and improve quality, as well as suggests that some
of these activities are associated with improvements in care. It expands on the findings of
previous research and indicates that state Medicaid agencies are continuing to mature and
further develop their capacity to evaluate and improve the quality of care received by
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beneficiaries in their managed care programs. However, similar to other studies on
quality improvement activities; this study does not evaluate the comparative effectiveness
of various strategies and their impact in different environments and across different
populations. While a number of articles have stressed the importance of strategies such
as pay for performance, public reporting, and performance improvement collaboratives, it
would be useful to evaluate the comparative effectiveness of each of these strategies.
With continuing pressure on Medicaid agencies to contain, or reduce expenditures, it
becomes increasingly important to be able to demonstrate the return on investments in
quality improvement. Without such data it may be difficult to obtain additional funding
from state legislatures for initiatives such as P4P programs, even with documentation that
they can improve quality.
To date, research on the role of Medicaid agencies in improving the quality of
care has largely relied on surveys and interviews of Medicaid or MCO staff regarding the
various initiatives that have been utilized. With the exception of studies that have
evaluated the use of P4P incentives, there have been few studies that have empirically
evaluated the impact of different quality improvement strategies. While the current study
found an association between P4P incentives and public reporting of data, and reported
improvement in performance measures, future research should more carefully assess the
specific components of these interventions that are associated with improvement in
healthy behaviors and health outcomes of Medicaid recipients.
Managed Medicaid programs typically have included low-income women and
children in their population, while leaving many with more significant medical needs,
such as the elderly, disabled, and medically needy populations in traditional fee-for-
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service programs. Findings from this study and previous studies have documented that
more states are including more of those with significant medical needs in their managed
care populations. With this shift, it will be important to evaluate the degree to which
managed care programs can effectively meet the needs of these populations, as well as to
assess whether different quality improvement strategies are more effective with these
different populations. One may find, for example, that while less intensive interventions,
such as public reporting, may be sufficient to improve care in low-income populations,
more intensive and more costly interventions (such as state-wide collaborative and P4P
incentives) may be necessary to improve care in a disabled population.
Finally, research on quality improvement at a health plan or Medicaid agency
level has typically focused on populations that are enrolled in managed care programs.
However, the findings from this study indicate that the quality programs of slightly over
half (52%) of the states responding had oversight over both their managed care and their
fee-for-service programs. Quality improvement activities in a non-managed care
program can be more difficult without external organizations that are contracted and
accountable for providing care. It would be interesting for future research to look at what
strategies states are using to evaluate and improve the quality in their non-managed care
programs, how these efforts are integrated with their managed care programs, and how
their effectiveness compares with those strategies used in a managed care environment.
Recommendations
Although CMS has established certain requirements for all states to meet
regarding implementation of a quality strategy for their managed care programs, these
requirements have not been structured in such a way that they allow meaningful
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comparisons between state Medicaid programs, or easily allow states to learn from each
others successes and failures. With virtually all states that have managed care programs
utilizing some HEDIS measures, CMS easily could begin to develop comparative
measures by establishing a core set of performance measures that all states would capture
and report. States could elect to report on additional standardized measures (from a finite
set) based upon their populations in managed care, and the areas that they have identified
as important for their state. A central Medicaid quality website could be established that
would report state data on these core measures in the same way that NCQA and many
states now report such data from individual health plans. This would allow states to
benchmark their performance against other states, set improvement goals, and measure
their performance over time. Such a site also would allow Medicaid agencies to share
tools and better practices, as well as to enhance collaboration with each other.
Along with improving the collection and reporting of standard performance
measures, it also will be important for states to improve their assessment of the quality of
preventive and developmental services delivered to children. While children make up a
significant proportion of Medicaid beneficiaries, particularly within managed care
programs, and Early Periodic Screening, Diagnostic, and Treatment services (EPSDT)
are federally mandated, Ireys et al (2005) found that few states did much more than
assess the number of children receiving services and counting the number of visits
received. This is consistent with the findings of the current study which the most
commonly reported performance measures assessing the number of children receiving a
well child visit. However, about half (48%) of the states surveyed reported that they also
used some other means to assess the quality of developmental services, such as medical
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record reviews, focus groups, or member surveys. While this is encouraging, the
development of standard measures and methods of assessment that specifically focus on
the provision of preventive and developmental services would assist state agencies in
collecting this information, and doing so in way that would allow comparative evaluation,
as well as aggregation of information across states.
Finally, although the focus of the study was on beneficiaries in managed care
plans, it is noteworthy that while 52% of the responding states indicated that their quality
programs had oversight over both managed care and fee-for-service programs, 48% of
the states’ quality programs only reviewed their managed care programs. While the Code
of Federal Regulations requires that states with managed care programs develop and
implement a quality strategy, there is no such requirement for traditional (fee-for-service
Medicaid). While not directly assessed by this study, the findings suggest that in many
states an organized program focused on improving quality does not exist for members in
traditional Medicaid. With approximately 35% of Medicaid beneficiaries continuing to
receive care through non-managed care programs (including many of the populations
with the greatest medical need), it will be important to broaden the scope of the quality
strategy to include all Medicaid recipients. This will ensure that state efforts toward
quality improvement are directed and prioritized across their entire population and that
resources for quality efforts are appropriately targeted based on an overall strategy, rather
than one focused solely on managed care.
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APPENDIX B. – COVER LETTER TO MEDICAID DIRECTORS
We are requesting your participation in a survey that is being conducted by Georgia State
University and the Georgia Department of Medical Assistance Plans. We are evaluating
the various approaches that state Medicaid agencies are taking to assure and improve the
quality of care that their recipients receive through managed health care organizations. A
primary objective of this project is to determine the approaches that are being used to
improve quality, and the degree to which these approaches can be used to assess quality
outcomes.
We are asking you to complete a web based survey that asks a variety of questions about
your quality program and oversight of Medicaid managed care organizations. The survey
consists primarily of checkbox responses and should take no more than 10 to 15 minutes
of your time. Your participation in this survey is voluntary and individual responses will
be kept confidential. If you would like to receive a report of the results you can submit
your contact information at the end of the survey and we will send you a summary of our
findings.
We are asking that one person from each state Medicaid program respond to this survey
by 1/30/2009. Ideally this will be the person most knowledgeable about your Medicaid
quality program. The survey can be accessed at
https://www.psychdata.com/s.asp?SID=126601
If you have any questions about this study please contact Dev Nair, PhD at
dnair3@student.gsu.edu.
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